RTOG 0627: Phase II Trial of Dasatinib in Patients with Recurrent Glioblastoma Multiforme
Effects of a Study Medication on Brain Tumors
Brief description of study.
The purpose of the study is to find out what effects dasatinib has on brain tumors.
Detailed description of study
The purpose of the study is to find out what effects dasatinib has on brain tumors.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Recurrent Glioblastoma Multiforme
-
Age: 100 years or below
-
Gender: All
This study investigates the effects of an investigational medication on brain tumors. Brain tumors are abnormal growths of cells in the brain that can affect how the brain works. The study aims to understand how this medication interacts with brain tumors and its potential effects.
Participants in this study will undergo various procedures to monitor the effects of the investigational medication on their brain tumors. These procedures may include imaging tests, blood tests, and other assessments to gather data on the medication's impact.
- Who can participate: Eligibility criteria are determined by the study team.
- Study details: Participants will be required to take the investigational medication as directed and attend scheduled study visits for assessments. A placebo may be used, which is an inactive substance that looks like the investigational medication but does not contain any medicine.
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or